Providing healthcare professionals a reliable and rapid test result is lifesaving for many patients. From single test, rapid lateral flow assays (LFA) to high- ...
Missing: investor relations
Information on valuation, funding, cap tables, investors, and executives for Immy. Use the PitchBook Platform to explore the full profile.
Missing: relations | Show results with:relations
40 YEARS OF DEVELOPMENT. IMMY manufactures, markets, and distributes innovative lines of diagnostic tests and reagents for infectious diseases.
Missing: investor relations
Feb 16, 2017 · The following slide deck was published by Imprimis Pharmaceuticals, Inc.
Missing: relations | Show results with:relations
Retune your immune system with ancient (friendly) bacteria. Meet immy, a ground-breaking supplement derived from a naturally occurring strain of bacteria that ...
Experience · Senior Financial Analyst, Investor Relations · Private Investor - Micro-Cap and Small-Cap · Investment Assistant to Chairman · Research Analyst.
Missing: immy | Show results with:immy
Imprimis Pharmaceuticals (IMMY) Investor Presentation - Slideshow · SA TranscriptsThu, Feb. 16, 2017. Imprimis Pharmaceuticals' (IMMY) CEO Mark Baum on Q3 2016 ...
Missing: relations | Show results with:relations
Analyze up to 10 years of full 10K Annual Reports and Quarterly 10Q SEC filings for Imprimis Pharmaceuticals, Inc. (IMMY) using our online tools.
People also ask
Who is the CEO of Immy com?
Signup for latest investor updates ... Presentation at the 27th Annual Meeting of the ... Patients are waiting! EMAIL ALERTS. Stay up to date on the latest news and
To listen to the webcast, please click here or visit the investor relations section of the Imprimis website by clicking here. A dial in replay of the call ...